ClinConnect ClinConnect Logo
Search / Trial NCT06019910

Snus and Home Blood Pressure

Launched by UNIVERSITY HOSPITAL, LINKOEPING · Aug 25, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of snus, a type of tobacco, on blood pressure and metabolism in people who have used it daily in the past. The main goal is to see how stopping snus affects home blood pressure over a few weeks to months, and what happens if someone starts using it again after quitting. Researchers will measure blood pressure and metabolic health markers in healthy volunteers who have used snus regularly for at least a month, both before they stop and if they go back to using it.

To participate in this study, you must be between the ages of 18 and 62, have used snus daily, and be able to fill out online questionnaires in Swedish. However, you cannot be using any other tobacco products, have a history of certain health conditions like heart disease or diabetes, or be pregnant. If you join, you can expect to be monitored for changes in your blood pressure and overall health during the study period. This research aims to provide valuable insights into how snus affects health over time, especially concerning blood pressure and metabolic health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • daily use (defined as at least once daily for at least 1 month) o snus
  • the ability to use online questionnaires written and answered in Swedish
  • Exclusion Criteria:
  • simultaneous use of any other nicotine or tobacco product (including cigarette smoking, e-cigarettes, and nicotine replacement therapy)
  • drug use (including cannabis)
  • alcohol dependence
  • known cardiovascular disease (including hypertension, previous myocardial infarction, stroke, peripheral arterial disease, or angina pectoris), kidney disease, hormonal disease (including diabetes mellitus) or eating disorder
  • current or planned pregnancy.

About University Hospital, Linkoeping

The University Hospital in Linköping is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pivotal institution within the region, it integrates cutting-edge medical practices with academic excellence, facilitating a collaborative environment for healthcare professionals and researchers. The hospital actively participates in a wide range of clinical trials across various medical disciplines, aiming to enhance patient outcomes and contribute to the global body of medical knowledge. With a focus on ethical standards and patient safety, the University Hospital in Linköping is dedicated to pioneering solutions that address pressing health challenges.

Locations

Norrköping, , Sweden

Patients applied

0 patients applied

Trial Officials

Fredrik H Nyström, PhD, MD

Principal Investigator

Linkoeping University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported